Kryptos Biotechnologies is developing Kuick, a rapid, accurate, easy-to-use and affordable molecular diagnostic system for point-of-care testing. The system uses proprietary Ultrafast Photonic PCR technology combined with sold-phase extraction in the sample preparation. The system ensures the best-in-class performance while providing test results on time.
The development of the system is completed and ready for validation study or clinical study.
Press Releases
Additional Info
Included in the Export Interest Directory?
YesBusiness Needs?
Direct Sales, Distributor/Agent/Representative, Investor, Joint Ventures, Licensing Agreements